Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Sci Transl Med. 2011 Oct 19;3(105):105ra105. doi: 10.1126/scitranslmed.3002884.

Preterm cerebellar growth impairment after postnatal exposure to glucocorticoids.

Author information

  • 1Departments of Neurology and Pediatrics, University of California, San Francisco, San Francisco, CA 94143, USA. emily.tam@ucsf.edu

Abstract

As survival rates of preterm newborns improve as a result of better medical management, these children increasingly show impaired cognition. These adverse cognitive outcomes are associated with decreases in the volume of the cerebellum. Because animals exhibit reduced preterm cerebellar growth after perinatal exposure to glucocorticoids, we sought to determine whether glucocorticoid exposure and other modifiable factors increased the risk for these adverse outcomes in human neonates. We studied 172 preterm neonatal infants from two medical centers, the University of British Columbia and the University of California, San Francisco, by performing serial magnetic resonance imaging examinations near birth and again near term-equivalent age. After we adjusted for associated clinical factors, antenatal betamethasone was not associated with changes in cerebellar volume. Postnatal exposure to clinically routine doses of hydrocortisone or dexamethasone was associated with impaired cerebellar, but not cerebral, growth. Alterations in treatment after preterm birth, particularly glucocorticoid exposure, may help to decrease risk for adverse neurological outcome after preterm birth.

Comment in

PMID:
22013125
[PubMed - indexed for MEDLINE]
PMCID:
PMC3682111
Free PMC Article

Images from this publication.See all images (2)Free text

Figure 1
Figure 2
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk